According to the latest analysis by Emergen Research, the size of the world Dermatology device market It is expected to reach $16.13 billion in 2030, with a revenue compound annual growth rate of 12.7%. One of the major reasons driving the revenue growth of this market is the high incidence of skin problems. Skin diseases spread all over the world and have a great impact on public health in both developed and underdeveloped countries. The most commonly diagnosed lesion is acne vulgaris, which affects more than 80% of people worldwide at some point in their lives and 85% of adolescents in rich countries.
Due to the almost complete suspension of non-COVID-19 measures, limited production activities, and disruption in the supply chain, the market witnessed negative growth in the short term. However, the market has experienced a V-shaped recovery. The number of dermal devices has begun to return to pre-pandemic levels with the successful introduction of vaccines in each region. Due to the backlog from 2020 and the increasing consumer interest and awareness of dermatological procedures, the market saw a huge demand in 2021. Recently, the market has experienced a lot of fluctuations.
For comprehensive information on forecast analysis of the global market, order a PDF brochure here @ https://www.emergenresearch.com/industry-report/dermatology-devices-market
The therapy device market, which will account for more than 79% of total sales in 2021, is also expected to grow at the fastest rate (CAGR) over the forecast period. This is primarily because dermatological treatments have many applications. The segment’s growth is also attributed to the introduction of new technologies in the lasers category. Because fewer people are familiar with many of the new equipment, diagnostic devices have a small share of the market. However, future segment expansion is expected to be fueled by the rising incidence of melanoma.
Some highlights of the report
On July 25, 2022, STRATA Skin Sciences, Inc. TheraClearX, Inc., a healthcare technology company that specializes in the development, development and commercialization of cutting-edge products for the treatment of dermatological conditions, TheraClearX in the United States. TheraClearX is a non-invasive, in-office acne treatment that targets the underlying causes of mild to moderate acne, such as pustular and inflammatory acne.
With access to many dermatological treatment options and the emergence of cutting-edge laser device technologies, the treatment device category is expected to receive the highest share of revenue during the projection period. For example, on August 17, 2020, Lumenis Ltd. NuEra Tight, Inc., a leading provider of energy-based medical devices for ophthalmic, surgical, and cosmetic applications, is NuEra Tight. Developing individualized, non-invasive body therapies using this technology, which specifically cater to each patient’s needs, helps drive market revenue.
Throughout the projection period, the diagnostics segment is expected to register a consistent CAGR. It is further divided into diagnoses of skin cancer and other conditions. The skin cancer diagnostics sub-segment has the highest revenue share due to the high prevalence of skin cancer. In addition, the advancement of skin cancer diagnostics through new research and development is boosting market revenue. For example, basal and squamous cell carcinomas are diagnosed in about 3.3 million Americans each year. Researchers at the Huntsman Cancer Institute (HCI) and the University of Utah have developed a device called URSKIN that uses invisible electrical impedance measurements to take advantage of changes in the skin’s electrical properties that occur during proliferating cancer cells (EID).
View full report description, research methodology, table of content, and graphs @ https://www.emergenresearch.com/industry-report/dermatology-devices-market
Emergen Research has segmented the global dermatology devices market into segments on the basis of product, application, end use, and region:
- Product Forecast (Revenue, Billion US$, 2019-2030)
- diagnostic devices
- treatment devices
- Application Forecast (Revenue, Billion USD, 2019-2030)
- diagnostic devices
- treatment devices
- End Use Forecast (Revenue, Billion USD, 2019-2030)
- Regional Outlook (Revenues, Billion US$, 2019-2030)
- North Amarica
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia and the Pacific
- Latin america
- Rest of Latin America
- Middle East and Africa
- Kingdom Saudi Arabia
- The United Arab Emirates
- South Africa
- Rest of the Middle East and Africa
- North Amarica
Emergen Research has a discount available for a limited time (grab a discounted copy now) @ https://www.emergenresearch.com/request-discount/1462
View additional reports by Emergen Research:
Emergen Research is a market research and advisory firm that provides syndicated research reports, customized research reports, and advisory services. Our solutions focus purely on your goal to identify, target and analyze consumer behavior shifts across demographics and across industries and help customers make smarter business decisions. We provide market intelligence studies to ensure relevant, fact-based research across multiple industries, including healthcare, touchpoints, chemicals, species, and energy. We are constantly updating our research offering to ensure that our clients are aware of the latest trends out there in the market. Emergen Research has a strong base of experienced analysts from various areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct line: +1 (604) 757-9756
Visit for more insights: https://www.emergenresearch.com/insights